The RetInSight Fluid Monitor for Neovascular Age-Related Macular Degeneration (nAMD)
Are you tired of manually searching for fluids in the OCTs of your patients? Exchange the cumbersome screening against an automated fluid detection and quantification in nAMD.
Key features of the RetInSight Fluid Monitor
- Precise visualization: Visualize retinal fluid types and location automatically and at one glance
- Accurate fluid measurement: Accurately measure fluid-related biomarkers, including intraretinal fluid (IRF), subretinal fluid (SRF), and pigment epithelial detachment (PED), in real-time with nanoliter precision2,3
- NEW FEATURE > Enhanced disease monitoring: Visualize and track disease progression, allowing for precise and timely interventions
The RetInSight Fluid Monitor fulfills all MDR 2017/745 requirements for class IIa medical devices as Clinical Decision Support Systems (CDSS) for the monitoring of patients with nAMD.
How the RetInSight Fluid Monitor will benefit your clinical routine
- Objective evaluation: Move from subjective to objective evaluation with the ability to quantify fluid dynamics in nAMD
- NEW FEATURE > Follow-up function: Generate a follow-up chart of fluid dynamics to track individual recurrence profiles and visualize disease progression over time, enabling improved disease management
- Efficient workflow: Integrate GA management seamlessly into your current optical coherence tomography (OCT) routine, streamlining workflow and enhancing efficiency
Real-time visualization supporting informed decisions in nAMD
Request more information on the Fluid Monitor today and witness the seamless integration of AI technology into nAMD care, allowing for informed decisions in the management of nAMD.
Together, let’s revolutionize the way we manage and treat nAMD. We look forward to hearing from you.